VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg
C4951004/BHV3000-406
Approved small_molecule active
Quick answer
VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg for Migraine attacks with or without aura is a Approved program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Migraine attacks with or without aura
- Phase
- Approved
- Modality
- small_molecule
- Status
- active